Senores Pharmaceuticals IPO
ListedSenores Pharmaceuticals IPO Details
-
Bidding Date
20-Dec-2024 to
24-Dec-2024 -
Issue Size
₹132.11 Cr
-
Price Band
₹372 to ₹391
-
Allotment date
26-Dec-2024
-
Listing date
30-Dec-2024
-
Lot size
38
-
No. of shares
33,78,772
-
Fresh issue/OFS
₹50 Cr/₹82.11 Cr
About Senores Pharmaceuticals Company
The core business of Senores Pharmaceuticals revolves around the identification, development, and commercialization of specialty, underpenetrated, and complex pharmaceutical products. The company primarily operates in regulated markets (US, Canada, UK), where it focuses on products that require significant regulatory compliance. It also caters to emerging markets through partnerships, distributors, and direct sales under various business models, such as distributor, P2P, and CDMO. The company manufactures and markets critical care injectables and Active Pharmaceutical Ingredients (APIs), further diversifying its product offerings. It operates through strategic partnerships with other pharmaceutical companies, including Prasco LLC, Lannett Company Inc., Jubilant Cadista Pharmaceuticals Inc., among others, to market products across different therapeutic areas.
Read our in-depth analysis of the Senores Pharmaceuticals Ltd IPO Here
Subscription Status
-
Category
Status
-
QIBs
94.7x
-
NIIs
96.1x
-
Retail
89.1x
-
Others
19.9x
-
Total
93.4x
FAQs for Senores Pharmaceuticals IPO.
What is the issue size of Senores Pharmaceuticals IPO?
The issue size of Senores Pharmaceuticals is ₹132.11 Cr.
What is the industry of Senores Pharmaceuticals?
Senores Pharmaceuticals falls into Pharmaceuticals industry.
Where Senores Pharmaceuticals IPO will be listed?
The Senores Pharmaceuticals IPO will be listed on both NSE and BSE.
What are the open and close dates for the Senores Pharmaceuticals IPO?
The open and close dates for the Senores Pharmaceuticals are 20-Dec-2024 & 24-Dec-2024.
What are the price band for Senores Pharmaceuticals IPO?
The price band for the Senores Pharmaceuticals ipo is ₹372 to ₹391
What is the listing date of Senores Pharmaceuticals IPO?
The listing date of Senores Pharmaceuticals IPO is 30-Dec-2024.
What is the purpose for the Senores Pharmaceuticals IPO?
The purpose of this IPO is to raise fresh capital as well as enable the existing shareholders to sell their stake.
How much times Senores Pharmaceuticals IPO subscribed?
Senores Pharmaceuticals total subscription ratio is 93.4X.
What are the key financials for the Senores Pharmaceuticals IPO?
Key financial of the Senores Pharmaceuticals are:
| Senores Pharmaceuticals | FY-24 | FY-23 | FY-22 |
|---|---|---|---|
| Revenue (₹ Cr) | 214.52 | 35.34 | 14.17 |
| EBIT (₹ Cr) | 31.57 | 10.89 | 1.25 |
| Proft after Tax (₹ Cr) | 32.71 | 8.43 | 0.99 |
| Debt (₹ Cr) | 248.39 | 60.76 | 14.21 |
| Net Worth (₹ Cr) | 231.71 | 45.5 | 36.59 |
| RoE (%) | 14.12 | 18.53 | 2.71 |